In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
Gonzalez-Robles C, Bandmann O, Schapira AHV (2025) Neuroprotection in Parkinson disease
GHK-Cu has been shown to promote skin remodeling, wound healing, and regeneration and has prominent antioxidant and anti-inflammatory effects in in vitro and in vivo studies
Choosing where to receive your treatments matters
If youre struggling with persistent fatigue, we encourage you to schedule a visit with our providers
It contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial growth and keeps your reconstituted solution safe for the 3 to 4 weeks you will be drawing from the vial